top of page

BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress

Seth Ettenberg describes safety, imaging, and efficacy takeaways from the 12-patient study.



Comentarios


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page